Teresa I.A. Gouveia

Teresa I.A. Gouveia

Auto-generated profile, based on publicly available information

Teresa I.A. Gouveia

LEPABE - Laboratory for Process, Environmental, Biotechnology and Energy Engineering, Faculty of Engineering, University of Porto, R. Dr. Roberto Frias, 4200-465, Porto, Portugal; ALiCE - Associate Laboratory in Chemical Engineering, Faculty of Engineering, University of Porto, Rua Dr. Roberto Frias, 4200-465, Porto, Portugal

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2019 in Food Hydrocolloids
Verified
Journal Article
Closed access
TGTeresa I.A. Gouveia
Teresa I.A. Gouveia
KBKrzysztof Biernacki
Krzysztof Biernacki
CCCidália Castro
Cidália Castro
MGMaria P. Gonçalves
Maria P. Gonçalves
HSHiléia Karla Silva Souza
Hiléia Karla Silva Souza

9 August 2022 in Journal of Hazardous Materials
Verified
Journal Article
Closed access
Alicia Loreto García CostaAlicia Loreto García Costa
Alicia Loreto García Costa
TGTeresa I.A. Gouveia
Teresa I.A. Gouveia
Manuel Fernando PereiraManuel Fernando Pereira
Manuel Fernando Pereira
Adriano dos Santos SilvaAdriano dos Santos Silva
Adriano dos Santos Silva
Luis M. MadeiraLuis M. Madeira
Luis M. Madeira
Mónica SantosMónica Santos
Mónica Santos

6 June 2023 in Environmental Pollution
Verified
Journal Article
Open access
TGTeresa I.A. Gouveia
Teresa I.A. Gouveia
MCMaria B. Cristóvão
Maria B. Cristóvão
VPVanessa J. Pereira
Vanessa J. Pereira
JCJoão G. Crespo
João G. Crespo
AAArminda Alves
Arminda Alves
Mónica SantosMónica Santos
Mónica Santos
Antineoplastic drugs are pharmaceuticals that have been raising concerns among the scientific community due to: (i) their increasing prescription in the fight against the disease of the twentieth century (cancer); (ii) their recalcitrance to conventional wastewater treatments; (iii) their poor environmental biodegradability; and (iv) their potential risk to any eukaryotic organism. This emerges the urgency in finding solutions to mitigate the entrance and accumulation of these hazardous chemicals in the environment. Advanced oxidation processes (AOPs) have been taken into consideration to improve the degradation of antineoplastic drugs in wastewater treatment plants (WWTPs), but the formation of by-products that are more toxic or exhibit a different toxicity profile than the parent drug is frequently reported. This work evaluates the performance of a nanofiltration pilot unit, equipped with a Desal 5DK membrane, in the treatment of real WWTP effluents contaminated (without spiking) with eleven pharmaceuticals, five of which were never studied before. Average removals of 68 ± 23% were achieved for the eleven compounds, with decreasing risks from feed to permeate for aquatic organisms from receiving waterbodies (with the exception of cyclophosphamide, for which a high risk was estimated in the permeate). Aditionally, no significative impact on the growth and germination of three different seeds (Lepidium sativum, Sinapis alba, and Sorghum saccharatum) were determined for permeate matrix in comparison to the control.

17 October 2023 in Journal of Environmental Management
Verified
Journal Article
Open access
TGTeresa I.A. Gouveia
Teresa I.A. Gouveia
AGAna M. Gorito
Ana M. Gorito
MCMaria B. Cristóvão
Maria B. Cristóvão
VPVanessa J. Pereira
Vanessa J. Pereira
JCJoãog. Crespo
Joãog. Crespo
Mónica SantosMónica Santos
Mónica Santos
Over the past years, there has been an increasing concern about the occurrence of antineoplastic drugs in water bodies. The incomplete removal of these pharmaceuticals from wastewaters has been confirmed by several scientists, making it urgent to find a reliable technique or a combination of techniques capable to produce clean and safe water. In this work, the combination of nanofiltration and ozone (O3)-based processes (NF + O3, NF + O3/H2O2 and NF + O3/H2O2/UVA) was studied aiming to produce clean water from wastewater treatment plant (WWTP) secondary effluents to be safely discharged into water bodies, reused in daily practices such as aquaculture activities or for recharging aquifers used as abstraction sources for drinking water production. Nanofiltration was performed in a pilot-scale unit and O3-based processes in a continuous-flow column. The peroxone process (O3/H2O2) was considered the most promising technology to be coupled to nanofiltration, all the target pharmaceuticals being removed at an extent higher than 98% from WWTP secondary effluents, with a DOC reduction up to 92%. The applicability of the clean water stream for recharging aquifers used as abstraction sources for drinking water production was supported by a risk assessment approach, regarding the final concentrations of the target pharmaceuticals. Moreover, the toxicity of the nanofiltration retentate, a polluted stream generated from the nanofiltration system, was greatly decreased after the application of the peroxone process, which evidences the positive impact on the environment of implementing a NF + O3/H2O2 process.

28 August 2023
Verified
Conference Paper
Closed access
TGTeresa Gouveia
Teresa Gouveia
IMIsabel Mota
Isabel Mota
Adriano dos Santos SilvaAdriano dos Santos Silva
Adriano dos Santos Silva
AAA. Alves
A. Alves
Mónica SantosMónica Santos
Mónica Santos